Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
35
-
Total shares
-
7.32M
-
Shares change
-
-438K
-
Total reported value, excl. options
-
$73.7M
-
Value change
-
+$169K
-
Number of buys
-
21
-
Number of sells
-
-15
-
Price
-
$10.07
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q4 2014
35 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q4 2014.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.32M shares
.
Largest 10 shareholders include Cormorant Asset Management, LLC (1.75M shares), JPMORGAN CHASE & CO (1.14M shares), venBio Select Advisor LLC (910K shares), VANGUARD GROUP INC (432K shares), Talkot Capital, LLC (385K shares), BlackRock Institutional Trust Company, N.A. (372K shares), BAIRD ROBERT W & CO INC /WI/ (344K shares), CAM Group Holding A/S (272K shares), DEUTSCHE BANK AG\ (229K shares), and Tekla Capital Management LLC (214K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.